NCT01819558View on ClinicalTrials.gov

Phase I/II Study of Immune Therapy After Allograft in Patients With Myeloid Hemopathy

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Acute Myeloid LeukemiaChronic Myeloid LeukemiaMyelodysplastic Syndrome
Interventions
BIOLOGICAL

recwt1-A10+AS01B

Trial Locations (1)

13009

Institut Paoli-Calmettes, Marseille

All Listed Sponsors
lead

Institut Paoli-Calmettes

OTHER

NCT01819558 - Phase I/II Study of Immune Therapy After Allograft in Patients With Myeloid Hemopathy | Biotech Hunter | Biotech Hunter